Latest News
Featured News
Director Dealing
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell announces late-breaking abstract presenting positive data from the first stage in its Phase 2 SCOPE trial
Preliminary Results for the year ended 30 April 2023
Update on Final Results
Scancell to present at the 2023 World Vaccine Congress Europe
Block Listing Six Monthly Return
Change of Date for Final Results and Investor Presentation
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.